Peptic Ulcer Market Future Outlook: Strong Growth Expected Toward $5.15 Billion by 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the peptic ulcer market from 2026–2035 with trusted insights from The Business Research Company
By how much is the Peptic Ulcer Market expected to grow between 2026 and 2030?
The peptic ulcer market has experienced consistent expansion in recent times. This market is projected to expand from $4.22 billion in 2025 to reach $4.35 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 3.3%. Historically, this expansion has been driven by factors such as the high prevalence of h. pylori infections, insufficient awareness regarding peptic ulcer complications, the extensive use of nsaids, reliance on traditional symptomatic treatments, and shortcomings in early diagnosis.
The peptic ulcer market is projected to experience consistent expansion over the upcoming years, with forecasts indicating it will reach $5.16 billion by 2030 at a compound annual growth rate (CAGR) of 4.3%. This anticipated growth can be linked to several factors, including the greater acceptance of proton pump inhibitors and antibiotics, an increase in hospital and private clinic treatment options, heightened understanding of preventive health measures, advancements in non-invasive diagnostic methods, and the broadening of e-commerce and retail pharmacy distribution networks. Furthermore, key trends anticipated during this period encompass the growing integration of AI-powered diagnostic tools, the development of personalized ulcer therapies leveraging genomics, the application of cloud and big data solutions for patient oversight, the incorporation of IoT devices for distant symptom monitoring, and sophisticated production techniques for ulcer treatments.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13221&type=smp
Which Drivers Are Influencing Market Acceleration In The Peptic Ulcer Market?
The expanding incidence of obesity is anticipated to fuel the expansion of the peptic ulcer market in the future. Obesity, a health condition marked by excessive body fat accumulation, typically corresponds to a body mass index (BMI) of 30 or more. It can stem from genetic predispositions, environmental influences, and lifestyle choices, including inadequate diet and insufficient physical activity. This condition leads to an overproduction of stomach acid, compromises the stomach’s protective mucosal lining, and thus contributes to the formation of peptic ulcers. Furthermore, excess body weight appears to encourage gastrointestinal inflammation, potentially resulting in peptic ulcer development. For example, the World Health Organization, an intergovernmental international organization based in Switzerland, reported in May 2025 that 35 million children under 5 years old were classified as overweight in 2024. Consequently, the increasing prevalence of obesity is a key driver for the growth of the peptic ulcer market. Rising smoking rates are projected to boost the growth of the peptic ulcer market in the foreseeable future. Smoking involves inhaling and exhaling the fumes from burning plant-derived substances like tobacco or marijuana. It is a recognized contributor to peptic ulcer disease, increasing its occurrence by damaging the stomach and duodenal linings, reducing blood flow to the stomach, and raising stomach acid levels. For example, the Organisation for Economic Co operation and Development, a France-based intergovernmental international organization, stated in November 2025 that in 2023, 14.8% of individuals aged 15 and above smoked daily across OECD countries. The highest percentages of daily smokers were observed in Türkiye, Hungary, and Greece, along with accession/partner countries Indonesia, Bulgaria, and China, where a minimum of one in four people smoked daily. Consequently, the escalating smoking rates are fueling the peptic ulcer market.
What Segments Are Identified Within The Structure Of The Peptic Ulcer Market?
The peptic ulcer market covered in this report is segmented –
1) By Disease Indication: Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)
2) By Drug Type: Proton Pump Inhibitors (PPI), H2 Antagonists, Antibiotics, Other Drugs
3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Store, Retail Pharmacies, E-Commerce
Subsegments:
1) By Gastritis: Acute Gastritis, Chronic Gastritis
2) By Gastric Ulcer: Acute Gastric Ulcer, Chronic Gastric Ulcer
3) By Duodenal Ulcer: Acute Duodenal Ulcer, Chronic Duodenal Ulcer
4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD, Erosive GERD
What Trends Are Driving The Growth Trajectory Of The Peptic Ulcer Market?
Major companies operating in the peptic ulcer market are increasingly focusing on the development of innovative solutions, such as combination therapy drug kits, to satisfy the growing requirement for effective H. pylori eradication and ulcer management. These combination therapy kits integrate multiple active ingredients within a single regimen, which improves treatment adherence and offers a more targeted approach compared to traditional single-drug therapies. For instance, in April 2023, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical formulations and APIs company, launched Combikit, an advanced three-drug formulation. The Combikit contains amoxicillin, clarithromycin, and esomeprazole, specifically designed to simultaneously handle bacterial elimination, acid suppression, and ulcer healing. It has received approval from the Central Drugs Standard Control Organisation (CDSCO) for treating duodenal ulcers associated with Helicobacter pylori (H. pylori) and for eradicating H. pylori in patients with either active or healed peptic ulcers. By combining these complementary mechanisms of action, the kit enhances the overall treatment efficacy, reduces the likelihood of ulcer recurrence, and improves patient compliance, particularly in regions experiencing high H. pylori prevalence.
Which Key Market Players Are Investing In Expansion And Innovation Within The Peptic Ulcer Market?
Major companies operating in the peptic ulcer market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report
Which Regions Are Poised For Strategic Growth In The Peptic Ulcer Market?
North America was the largest region in the peptic ulcer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Peptic Ulcer Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13221&type=smp
Browse Through More Reports Similar to the Global Peptic Ulcer Market 2026, By The Business Research Company
Duodenal Ulcer Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/duodenal-ulcer-treatment-global-market-report
Gastric Ulcers Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report
Pressure Ulcers Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/pressure-ulcers-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
